James C Foster insider trades: Charles River Laboratories International (CRL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
186 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | CRL | ↓ Sell10b5-1 | 24,042 | $350.00 | $8.4M | Direct | Oct 26, 2026 (4d) |
| Aug 25, 2026 | CRL | ↓ Sell10b5-1 | 33,561 | $300.00 | $10.1M | Direct | Aug 27, 2026 (2d) |
| Aug 10, 2026 | CRL | ↓ Sell10b5-1 | 28,733 | $275.00 | $7.9M | Direct | Aug 11, 2026 (1d) |
| Jun 29, 2026 | CRL | ↓ Sell10b5-1 | 75,000 | $225.00 | $16.9M | Direct | Jul 1, 2026 (2d) |
| Feb 20, 2025 | CRL | ↑ Buy | 6,075 | $165.01 | $1.0M | Direct | Feb 21, 2025 (1d) |
| Aug 1, 2024 | CRL | ↓ Sell | 25,000 | $250.00 | $6.3M | Direct | Aug 5, 2024 (4d) |
| Nov 14, 2023 | CRL | ↑ Buy | 5,620 | $178.05 | $1.0M | Direct | Nov 15, 2023 (1d) |
| Feb 15, 2023 | CRL | ↓ Sell | 20,000 | $250.00 | $5.0M | Direct | Feb 17, 2023 (2d) |
| Feb 23, 2022 | CRL | ↓ Sell | 20,296 | $287.83 | $5.8M | Direct | Feb 25, 2022 (2d) |
| Feb 22, 2022 | CRL | ↓ Sell | 17,436 | $288.67 | $5.0M | Direct | Feb 23, 2022 (1d) |
| Feb 15, 2022 | CRL | ↓ Sell | 20,000 | $315.46 | $6.3M | Direct | Feb 17, 2022 (2d) |
| Aug 6, 2021 | CRL | ↓ Sell | 10,000 | $401.79 | $4.0M | Direct | Aug 10, 2021 (4d) |
| Jun 1, 2021 | CRL | ↓ Sell | 9,577 | $332.23 | $3.2M | Direct | Jun 3, 2021 (2d) |
| May 7, 2021 | CRL | ↓ Sell | 7,500 | $343.17 | $2.6M | Direct | May 10, 2021 (3d) |
| Feb 24, 2021 | CRL | ↓ Sell | 24,009 | $284.75 | $6.8M | Direct | Feb 25, 2021 (1d) |
| Feb 23, 2021 | CRL | ↓ Sell | 37,731 | $281.27 | $10.6M | Direct | Feb 24, 2021 (1d) |
| Feb 11, 2021 | CRL | ↓ Sell | 30,000 | $285.02 | $8.6M | Direct | Feb 16, 2021 (5d) |
| Nov 2, 2020 | CRL | ↓ Sell | 22,000 | $232.38 | $5.1M | Direct | Nov 3, 2020 (1d) |
| Aug 7, 2020 | CRL | ↓ Sell | 24,000 | $217.49 | $5.2M | Direct | Aug 10, 2020 (3d) |
| May 18, 2020 | CRL | ↓ Sell | 17,435 | $175.00 | $3.1M | Direct | May 19, 2020 (1d) |
| May 11, 2020 | CRL | ↓ Sell | 17,446 | $162.53 | $2.8M | Direct | May 13, 2020 (2d) |
| Feb 26, 2020 | CRL | ↓ Sell | 25,124 | $162.25 | $4.1M | Direct | Feb 27, 2020 (1d) |
| Feb 24, 2020 | CRL | ↓ Sell | 44,303 | $166.70 | $7.4M | Direct | Feb 26, 2020 (2d) |
| Feb 24, 2020 | CRL | ↓ Sell | 3,000 | $167.83 | $503K | By Trust | Feb 26, 2020 (2d) |
| Feb 13, 2020 | CRL | ↓ Sell | 15,000 | $171.90 | $2.6M | Direct | Feb 14, 2020 (1d) |
| Feb 27, 2019 | CRL | ↓ Sell | 4,374 | $140.84 | $616K | Direct | Mar 1, 2019 (2d) |
| Feb 27, 2019 | CRL | ↓ Sell | 3,957 | $140.55 | $556K | Direct | Mar 1, 2019 (2d) |
| Feb 27, 2019 | CRL | ↓ Sell | 3,459 | $140.24 | $485K | Direct | Mar 1, 2019 (2d) |
| Feb 27, 2019 | CRL | ↓ Sell | 3,312 | $142.06 | $471K | Direct | Mar 1, 2019 (2d) |
| Feb 27, 2019 | CRL | ↓ Sell | 3,263 | $141.74 | $463K | Direct | Mar 1, 2019 (2d) |
| Feb 27, 2019 | CRL | ↓ Sell | 2,699 | $141.39 | $382K | Direct | Mar 1, 2019 (2d) |
| Feb 27, 2019 | CRL | ↓ Sell | 513 | $142.49 | $73K | Direct | Mar 1, 2019 (2d) |
| Feb 26, 2019 | CRL | ↓ Sell | 5,072 | $139.72 | $709K | Direct | Feb 28, 2019 (2d) |
| Feb 26, 2019 | CRL | ↓ Sell | 4,135 | $139.52 | $577K | Direct | Feb 28, 2019 (2d) |
| Feb 26, 2019 | CRL | ↓ Sell | 3,756 | $141.75 | $532K | Direct | Feb 28, 2019 (2d) |
| Feb 26, 2019 | CRL | ↓ Sell | 3,673 | $140.25 | $515K | Direct | Feb 28, 2019 (2d) |
| Feb 26, 2019 | CRL | ↓ Sell | 3,499 | $139.94 | $490K | Direct | Feb 28, 2019 (2d) |
| Feb 26, 2019 | CRL | ↓ Sell | 3,358 | $140.53 | $472K | Direct | Feb 28, 2019 (2d) |
| Feb 26, 2019 | CRL | ↓ Sell | 1,630 | $143.71 | $234K | Direct | Feb 28, 2019 (2d) |
| Feb 25, 2019 | CRL | ↓ Sell | 8,285 | $144.53 | $1.2M | Direct | Feb 26, 2019 (1d) |
| Feb 25, 2019 | CRL | ↓ Sell | 7,643 | $144.69 | $1.1M | Direct | Feb 26, 2019 (1d) |
| Feb 25, 2019 | CRL | ↓ Sell | 6,295 | $144.32 | $908K | Direct | Feb 26, 2019 (1d) |
| Feb 25, 2019 | CRL | ↓ Sell | 5,966 | $145.20 | $866K | Direct | Feb 26, 2019 (1d) |
| Feb 25, 2019 | CRL | ↓ Sell | 5,002 | $145.40 | $727K | Direct | Feb 26, 2019 (1d) |
| Feb 25, 2019 | CRL | ↓ Sell | 4,076 | $145.78 | $594K | Direct | Feb 26, 2019 (1d) |
| Feb 25, 2019 | CRL | ↓ Sell | 4,036 | $144.91 | $585K | Direct | Feb 26, 2019 (1d) |
| Feb 25, 2019 | CRL | ↓ Sell | 3,000 | $146.02 | $438K | Direct | Feb 26, 2019 (1d) |
| Jan 8, 2019 | CRL | ↓ Sell | 25,000 | $115.00 | $2.9M | Direct | Jan 10, 2019 (2d) |
| Dec 10, 2018 | CRL | ↓ Sell | 4,308 | $126.41 | $545K | Direct | Dec 12, 2018 (2d) |
| Dec 10, 2018 | CRL | ↓ Sell | 4,120 | $127.10 | $524K | Direct | Dec 12, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRL insiders
Open-market trades in the last 12 months
About James C Foster's insider trades
James C Foster is a director at Charles River Laboratories International (CRL). Since May 6, 2005, James has reported 2 open-market purchases worth $2.0M and 184 sales worth $296.0M on SEC Form 4. In the last 12 months: 4 sales ($43.3M).
4 sales (15% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (66 filings), option exercises (65 filings), gifts (34 filings), grants and awards (34 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.